As part of the Unit of Comparative Medicine at the University of Puerto Rico, the Animal Resources Center is a centralized facility accredited by AAALAC International. We provide housing, husbandry, and veterinary services for animals used in research at the Institution and external companies including support for preclinical and IND-enabling studies.
SANOFI
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. | x
RoviSys
RoviSys specializes in GMP compliant manufacturing automation, building automation, and information solutions tailored for the Life Sciences industries. Our solutions enable organizations to improve product quality, reliability, and data visibility while addressing unique challenges. Our customers gain a partner who enables them to go confidently from assessment & implementation to maintenance & optimization. At RoviSys, the most important thing we do is listen, because we’re committed to understanding your goals, your challenges, and your operations and delivering solutions with measurable results and clear return on investment. We have earned a reputation of quality and continuity since 1989, built on technical expertise, attentive customer service, and a commitment to vendor independence. We’re proud that our clients know RoviSys as a trustworthy partner who has helped make their business stronger and more profitable. As an independent organization and an approved system integrator for a wide range of control systems and MES platforms, RoviSys can meet diverse client needs. Our independence combined with experience on multilevel projects results in efficiency and quality in the creation of functional specifications, process documentation, electrical design, and system configuration. | RoviSys is a leader in system integration and a trusted partner to pharmaceutical, biotech, and life sciences companies worldwide. We are committed to delivering automation and information solutions that improve compliance, efficiency, and profitability. With expertise in manufacturing automation, MES, information management, building automation, and Industrial AI, we help clients boost productivity, ensure data integrity, and enhance product quality. From single-site upgrades to enterprise-wide digital transformations, RoviSys provides vendor-independent solutions backed by proven project management and deep industry knowledge. Our focus on measurable results and regulatory compliance helps life sciences companies stay competitive in a rapidly evolving global marketplace. | RoviSys is an independent control system integrator founded in 1989. As one of the first control systems integrators in North America, RoviSys has evolved to become a leading independent provider of comprehensive process automation solutions and services. | RoviSys is a global independent control systems integrator delivering results in the Process Automation, Manufacturing Execution System, Building Management System, Digital Transformation, Industrial AI, and Industrial Networking sectors. | RoviSys has successfully developed and implemented process control and automation systems, historians and reporting, and add in our expertise with custom EBR and MES solutions for the pharmaceutical and life science industries. We understand specific challenges associated with integrating process control systems and business information systems, and provide independent solutions for quality and compliance. Biotechnology, Pharmaceutical, and Medical Device companies’ missions are to deliver life saving medicines and products to patients around the world. It is our mission to help them do so efficiently and with the utmost level of quality. RoviSys offers GMP compliant manufacturing automation, building automation, and information solutions expertise that enables your organization to improve product quality, reliability, and data visibility. With a toolbox of proven solutions, expert resources, large-scale project management skills, and a pragmatic get-it-done attitude, RoviSys helps pharmaceutical, biotech, and medical device manufacturers stay competitive and secure. Go confidently from assessment & implementation to maintenance & optimization with RoviSys. | Since its founding in 1989 as one of the first control systems integrators in North America, RoviSys has evolved to become a leading independent provider of comprehensive process automation solutions and services.With the resources, experience and skills to solve and support practically any process automation and integration challenge, the company’s more than 500 engineers, developers and project managers make RoviSys an excellent choice for companies of all sizes looking for real solutions.RoviSys is a control system integrator and product development company with a foot planted firmly in the old and the new worlds of technology. Our engineers and developers know proprietary systems: Before joining RoviSys, many of them created some of the most successful large-scale control systems of the last decade.
PolyGhost Technologies
Engineering the Future of Mixing, Dosing, Separation, and Distribution Systems PolyGhost Technologies is an IP-driven hardware innovation company based in Bayamón, Puerto Rico, developing a portfolio of disruptive, compact, and energy-efficient technologies for fluid and solid handling across over 20 global industries. Founded in 2019 PolyGhost’s modular products eliminate the complexity, energy waste, and space demands of legacy systems used in water treatment, food processing, chemicals, oil & gas, pharmaceuticals, and beyond. The company’s product suite includes robotic sludge distribution, inline mixing/dosing skids, powder dissolution, self-cleaning filters, sludge thickeners, dry conveyor systems, and most recently, the HammerHead™ precision sludge-poly conditioning technology. PolyGhost’s Core Technologies: 1. Ghost Scooper™ Technology (Patent Pending): A modular rotary robotic mechanism that handles the distribution, displacement, mixing, filling, or conveying of dry and dewatered materials across open or enclosed containers. 2. Octopus Dosi-Mix™ Pump (2025 USPTO Patent): A pneumatic or electric inline mixing and dosing pump, integrating blending, aging, and delivery in one compact unit. 3. Ghost Mixing Reactor™ (2020 USPTO Patent): A four-zone continuous blending chamber designed to replace bulky polymer tanks, mixers, and external dosing systems. 4. CAT-5™ Jet Propulsion Dry Powder Dissolution Pump (2023 USPTO Patent) An inline dry powder-to-liquid dissolution system using jet propulsion force. It eliminates the need for aging tanks, feeders, and agitators. 5. Automatic Self-Cleaning Filter (2025 USPTO Patent): A patented self-cleaning inline strainer featuring a submersible drive and internal spiral cleaning brush (stainless steel, Kevlar, or custom bristles). 6. HammerHead™ Precision Sludge Poly Conditioning Tech (New 2025) 7. Ghost Inline Sludge Thickener (Prototype Phase – 2025) Others tech under development. Innovation Never Sleeps…
PBSV (PharmaBioServ)
PharmaBioServ was established in 1993 in Puerto Rico, offering compliance and validation consulting services to the Pharmaceutical industry. PharmaBioServ became the fastest growing technology transfer, project management, compliance, regulatory and validation company on the region. This rapid evolution, together with the client’s positive testimonials and referrals enabled an accelerated expansion of the company services portfolio. Today, PBSV serves all Health Sciences regulated industries in more than 30 countries around the Globe.
OcyonBio
OcyonBio is a game-changing company that offers an innovative solution to the challenges faced by life science organizations in manufacturing and development. We provide dedicated autonomous manufacturing capacity, along with an interconnected infrastructure and cutting-edge systems, to support every stage of the product lifecycle—from early development and pre-clinical phases to clinical trials and commercial production. Unlike traditional approaches, OcyonBio operates as a next-generation cGMP incubator space, boasting a comprehensive range of regulatory capabilities and abundant resources. Our goal is to empower our partners with the necessary tools and support to generate critical CMC data, facilitating smooth and efficient regulatory applications. With OcyonBio, companies can bid farewell to the costly and time-consuming process of building their own facilities. We offer a flexible solution that safeguards intellectual property, streamlines project schedules, optimizes resource allocation, and minimizes the risks associated with new product introduction. By eliminating the need for expensive infrastructure, we reduce overall costs, freeing up resources that can be allocated towards research, development, and innovation. Our manufacturing and development spaces are carefully designed to operate autonomously, ensuring maximum efficiency and productivity. At the same time, they remain interconnected with essential systems to meet the clinical and commercial requirements of our partners. This interconnectedness enables seamless collaboration and information flow, further enhancing the success of your projects. Partnering with OcyonBio means gaining access to a state-of-the-art facility without the burden of construction costs, while enjoying the flexibility to adapt and scale operations according to your needs. We empower you to focus on what matters most—advancing your life science initiatives—while we take care of the manufacturing and development processes. Experience the future of manufacturing and development with OcyonBio. Together, we will revolutionize the life sciences industry, unlocking new possibilities and achieving groundbreaking results. Contact us today to embark on a transformative journey towards success. | OcyonBio redefines innovation in life sciences manufacturing and development. Our tailored solutions address key industry challenges, offering dedicated autonomous manufacturing capabilities and a seamlessly integrated infrastructure. By covering every stage of the product lifecycle, from early development to commercial production, we streamline the path to market success. As pioneers of next-generation cGMP incubator spaces, OcyonBio provides expansive regulatory expertise and abundant resources. Our mission is to equip our partners with essential tools for generating critical CMC data, ensuring efficient regulatory submissions. Choose OcyonBio and say goodbye to the burdens of constructing your own facilities. Our flexible, secure solutions protect intellectual property, enhance project timelines, and optimize resource use, all while minimizing risk during new product introductions. Our approach not only cuts costs but also reallocates savings to foster further research, development, and innovation. Our facilities are designed for peak efficiency and productivity, maintaining connectivity with vital systems to support both clinical and commercial demands. This integration fosters unparalleled collaboration and information exchange, propelling your projects forward. By partnering with OcyonBio, you gain access to cutting-edge facilities without the overhead of construction costs, coupled with the agility to scale operations as needed. Focus on advancing your initiatives; we’ll handle the complex manufacturing and development logistics. Discover the future of life science manufacturing with OcyonBio. Join us in revolutionizing the industry, unlocking new possibilities, and achieving extraordinary outcomes. Contact us today to start your transformative journey toward success. | OcyonBio – Empowering Innovation in Advanced Therapies Headquartered in Aguadilla, Puerto Rico, OcyonBio is a next-generation contract development and manufacturing organization (CDMO) specializing in the development and commercial manufacturing of biologics, cell and gene therapies (CGT), and aseptic drug products. With a foundation built on flexibility, speed, and regulatory excellence, OcyonBio provides integrated solutions for companies developing complex, life-saving therapies. Our Mission To enable biotechnology innovators to bring breakthrough therapies to market faster and more efficiently by providing world-class infrastructure, tailored contract development and manufacturing organization (CDMO) services, and a unique partnership model that empowers scientific teams. Our Services OcyonBio offers a comprehensive suite of services to support the entire development lifecycle: 1. Biologics and CGT Manufacturing • Cell Therapy: Autologous and allogeneic platforms, including CAR-T, TCR, and stem cell-based therapies. • Gene Therapy: Viral vector production (AAV, LV), plasmid DNA production, and fill-finish. • Biologics Drug Substance Manufacturing: Monoclonal antibodies and other recombinant proteins produced using mammalian expression systems (e.g., CHO). • GMP Suites: Modular, BSL-2 compliant cleanroom spaces for Phases I–III and commercial production. 2. Aseptic Fill & Finish • State-of-the-art isolator-based systems for vial and syringe filling. • Flexible batch sizes support clinical through commercial-scale products. 3. Analytical Development & Quality Control • Custom assay development for identity, purity, potency, and safety. • In-house microbiology, molecular biology, and biochemical analytics. • Stability studies, method validation, and release testing. 4. Regulatory & Quality Support • Full cGMP compliance under FDA and EMA guidelines. • Support for IND, IMPD, and BLA submissions. • Quality-by-Design (QbD) implementation and risk-based validation strategies. 5. Development & Technology Transfer • Process development and scale-up from R&D to GMP. • Tech transfer frameworks that minimize risk and timelines. • Collaborative team integration between client scientists and OcyonBio experts. Flexible Infrastructure Model OcyonBio offers a hybrid model that combines the benefits of a Contract Development and Manufacturing Organization (CDMO) with the autonomy of dedicated, client-operated space. Companies can lease customizable GMP suites, QC labs, and support areas within our purpose-built campus while accessing centralized services such as: • Centralized QA/QC and regulatory support • Supply chain and cold chain management • Utilities, warehousing, and environmental monitoring • Trained labor pool and technical assistance This unique model accelerates facility readiness while preserving control over critical manufacturing processes. Facilities OcyonBio’s 200,000+ square-foot campus in Aguadilla includes: • ISO 7/ISO 8 cleanrooms • Dedicated vector production suites • Aseptic filling lines with isolator technology • Analytical and QC laboratories • Office and training space for client teams • Modular expansion zones to meet growing capacity needs Puerto Rico offers a strategic geographic and regulatory advantage: U.S. jurisdiction, cost-effective labor, strong logistics, and significant tax incentives. Why Partner with OcyonBio? • Speed to Clinic and Market: Accelerated timelines through modular buildouts and technology transfer expertise. • Customized Engagement Models: From comprehensive CDMO services to co-located manufacturing partnerships. • Deep Expertise: Decades of experience across regulatory, operations, process development, and manufacturing. • Resilient Supply Chain: On-island capabilities minimize international shipping risks and ensure control over the supply chain. • Incentivized Operating Environment: Leverage Puerto Rico’s Act 60 incentives, workforce development programs, and export advantages. Your Partner from Discovery to Commercialization Whether you’re a biotech startup advancing a first-in-human product or an established biopharma seeking a strategic CGT manufacturing partner, OcyonBio offers the agility, infrastructure, and scientific depth to bring your innovations to life. Join us at BIO 2025 to explore how OcyonBio can support your next breakthrough.